The product, manufactured by Korean devicemaker the Standard Company, is used in endoscopic procedures to provide lift and contrast during resection of lesions in the gastrointestinal tract, according to a news release shared with Becker’s. It uses sodium hyaluronate for lift, methylene blue for contrast, and is supplied in a prefilled syringe.
Blue Eye additionally has double the long-lasting mucosal elevation, according to its website, reducing procedure times.
The injection also uses hyaluronic acid, a biopolymer in human dermis, making it biocompatible.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.